A Case of Severe Coronary Spasm Associated with 5-Fluorouracil Chemotherapy

被引:22
作者
Kim, Sang-Min
Kwak, Cheol-Hoon
Lee, Bora
Kim, Seong Beom
Sir, Jung-Ju
Cho, Wook-Hyun
Choi, Suk-Koo
机构
[1] Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital, Seoul
[2] Department of Internal Medicine, Cardiovascular Center, National Medical Center, Jung-gu, Seoul 100-799
关键词
Angina pectoris; Calcium channel blockers; Coronary vasospasm; Fluorouracil;
D O I
10.3904/kjim.2012.27.3.342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiotoxicity associated with 5-fluorouracil (FU) is an uncommon, but potentially lethal, condition. The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented. The electrocardiogram (ECG) showed pronounced ST elevation in the lateral leads, and the chest pain was resolved after infusion of nitroglycerin. A coronary angiogram (CAG) revealed that the patient had significant atherosclerosis in the proximal left circumflex artery. Coronary artery spasm with fixed stenosis was considered, and a drug-eluting stent was implanted. After 8 hours, the patient complained of recurring chest pain, paralleled by ST elevation on the ECG. The chest pain subsided after administration of intravenous nitroglycerin followed by sublingual nifedipine. Repeated CAG showed patency of the previous stent. This case supports the vasospastic hypothesis of 5-FU cardiac toxicity, indicating that a calcium channel blocker may be effective in the prevention or treatment of 5-FU cardiotoxicity.
引用
收藏
页码:342 / 345
页数:4
相关论文
共 12 条
[1]   ISCHEMIC CHEST PAIN AFTER 5-FLUOROURACIL THERAPY FOR CANCER [J].
BAKER, WP ;
DAINER, P ;
LESTER, WM ;
MARTY, AM ;
BLAIR, TP .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :497-498
[2]   5-FLUOROURACIL CARDIOTOXICITY - A CRITICAL-REVIEW [J].
GRADISHAR, WJ ;
VOKES, EE .
ANNALS OF ONCOLOGY, 1990, 1 (06) :409-414
[3]   Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine [J].
Jensen, SA ;
Sorensen, JB .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) :487-493
[4]  
Kleiman N S, 1987, Am J Med, V82, P566, DOI 10.1016/0002-9343(87)90465-7
[5]  
KUZEL T, 1990, CANCER-AM CANCER SOC, V65, P885, DOI 10.1002/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO
[6]  
2-H
[7]   Cardiotoxicity of de Gramont's regimen: Incidence, clinical characteristics and long-term follow-up [J].
Meydan, N ;
Kundak, I ;
Yavuzsen, T ;
Oztop, I ;
Barutca, S ;
Yilmaz, U ;
Alakavuklar, MN .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (05) :265-270
[8]   5-FLUOROURACIL CARDIOTOXICITY - LEFT-VENTRICULAR DYSFUNCTION AND EFFECT OF CORONARY VASODILATORS [J].
PATEL, B ;
KLONER, RA ;
ENSLEY, J ;
ALSARRAF, M ;
KISH, J ;
WYNNE, J .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1987, 294 (04) :238-243
[9]   CONTINUOUS AMBULATORY ECG MONITORING DURING FLUOROURACIL THERAPY - A PROSPECTIVE-STUDY [J].
REZKALLA, S ;
KLONER, RA ;
ENSLEY, J ;
ALSARRAF, M ;
REVELS, S ;
OLIVENSTEIN, A ;
BHASIN, S ;
KERPELFRONIOUS, S ;
TURI, ZG .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :509-514
[10]  
ROBBEN NC, 1993, CANCER-AM CANCER SOC, V71, P493, DOI 10.1002/1097-0142(19930115)71:2<493::AID-CNCR2820710235>3.0.CO